OMA Guidelines Bundle

Obesity-Related Diseases 2026

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1544298

Contents of this Issue

Navigation

Page 11 of 45

12 Description of Conditions Effects of Adiposopathy on CKM and Other Systems System Key Concepts Metabolic/endocrine • Insulin resistance • Diabetes mellitus type 2 • Metabolic syndrome • Hypothyroidism • Gestational diabetes • Dysfunctional adipocytes drive inflammation, endocrine dysregulation, and disrupt neurohormonal regulation. • Insulin resistance impairs glucose metabolism and is a key component of T2DM. • Immune dysregulation plays key role in autoimmune hypothyroidism. Cardiovascular • CAD • CVA • CHF • Dyslipidemia • Hypertension • Atrial fibrillation • HFpEF • HFrEF • Blood volume and cardiac output are increased, leading to chronic volume overload in CHF. • RAAS leads to sodium retention, volume overload, and cardiac remodeling. • SNS activity can increase blood vessel tone. • In atrial fibrillation, epicardial and paracardial fat secrete inflammatory and profibrotic factors. Gastrointestinal • MASLD • Gastroesophageal reflux disease (GERD) • Cholelithiasis • Irritable bowel syndrome (IBS) • Hernias • Chronic low-grade inflammation and insulin resistance contributes to MASLD and IBS, sensitizing enteric nerves to exacerbate pain. • Increased intraabdominal pressure can lead to GERD and abdominal hernias. • Chronic low-grade inflammation and tissue fibrosis can modify tissue response to increased biomechanical forces.

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity-Related Diseases 2026